Absolute Return Capital’s Elevance Health ELV Stock Holding History

Absolute Return Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-53,957	Closed	-$7.55M	–	125
2015 Q3	$7.55M	Sell	53,957 -89,292	-62%	-$13.4M	0.48%	64
2015 Q2	$23.5M	Buy	143,249 +51,262	+56%	+$8.19M	0.94%	10
2015 Q1	$14.2M	Sell	91,987 -113,224	-55%	-$16.1M	0.37%	86
2014 Q4	$25.8M	Sell	205,211 -122,648	-37%	-$15.2M	0.53%	57
2014 Q3	$39.2M	Sell	327,859 -119,824	-27%	-$13.7M	0.55%	44
2014 Q2	$48.2M	Buy	447,683 +2,855	+0.6%	+$294K	0.57%	30
2014 Q1	$44.3M	Sell	444,828 -379,315	-46%	-$34.3M	0.64%	22
2013 Q4	$76.1M	Buy	824,143 +71,715	+10%	+$6.37M	0.84%	14
2013 Q3	$62.9M	Sell	752,428 -209,227	-22%	-$17.9M	0.87%	9
2013 Q2	$78.7M	Buy	+961,655	New	+$72M	1.01%	6

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Absolute Return Capital's ELV Position: Q4 2015 in Review

Absolute Return Capital sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 53,957 shares — an estimated $7.55M sold.

Absolute Return Capital first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $78.7M in Q2 2013. 764 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Absolute Return Capital reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
Absolute Return Capital sold 53,957 Elevance Health shares in Q4 2015, an estimated $7.55M.
Absolute Return Capital first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
Absolute Return Capital's Elevance Health position peaked at $78.7M in Q2 2013.
764 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.